Our Mission:To discover,apply and disseminate knowledge through creative and innovative health research.
WHAT WE DO
KAVI Institute of Clinical Research focuses on four themes coupled with attractive career paths that are attracting the best talent in Africa and serve the best interests of the general
HOW WE WORK
The Clinical Trials track runs HIV vaccine trials in addition to trials for other products including chemotherapy drug trials. Finally, the Knowledge Translation track brings research, policy
OUR FOCUS AREAS
IKAVI Institute of Clinical Research focuses on four themes coupled with attractive career paths that are attracting the best talent in Africa and serve the best interests of the general
OUR STRATEGIC PILLARS
KAVI Institute of Clinical Research focuses on four themes coupled with attractive career paths that are attracting the best talent in Africa and serve the best interests of the general.
KAVI - Institute of Clinical Research
University of Nairobi
Featured News
International Conference on Health (ICH 2018)
University of Nairobi Research Week
HIV Vaccine Awareness Day May 2018
Processional march to mark HIV Vaccine Awareness Day in Kangemi on 18th May 2018
Every year on 18th May, the world marks the HIV Vaccine Awareness Day (HVAD). It is a day set aside to raise awareness of the continuing efforts by scientists to develop a vaccine against HIV- the virus that causes AIDS. It is also a day to honour all those who, in one way or the other, have contributed towards this global effort. This year, KAVI-Institute of clinical research (KAVI-ICR) of the University of Nairobi commemorated the day in Nairobi at the Kangemi Health centre.
KAVI-ICR and India’s NCBS collaborate to enhance vaccine development
The team from NCBS led by Lt. General Velu Nair, met the Vice-Chancellor, Prof. Peter Mbithi when they paid a courtesy call on him on March 21, 2018.
The University of Nairobi’s KAVI-Institute of Clinical Research (KAVI-ICR) and the National Centre for Biological Sciences (NCBS), India, have established and initiated a collaboration to spearhead vaccine development through enhanced technology. According to the Director, KAVI-ICR, Prof. Omu Anzala, the partnership will see the team expand metagenomics sequencing from selected target groups in India and Africa and inform the newly emerging pathogens such as Chikungunya and Dengue in their virology, pathology, the point of care diagnostics and vaccine designs.
NCBS in Collaboration with KAVI-ICR Vaccine & Technology Platform
Initiation of the Collaboration between NCBS (India) and KAVI-ICR (University Of Nairobi, Kenya) while training University of Nairobi staff on flow cytometry 19th to 23rd March 2018.
Upcoming Events
- days
- 3
- hours
- 11
- mins
- 32
- secs
- 54
Special Seminar
Identifying common themes to understand mechanisms of increased HIV acquisition.
Presented by Professor Tom Hope. Northwestern University, USA
Tuesday 21st August 2018 from 11.00am to 1.00pm
Venue: KAVI - ICR Boardroom
Our Partners
